Trgovina Astria Therapeutics, Inc. - ATXS CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | - | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.024068% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.001846% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | N/A |
Odpri* | N/A |
Enoletna sprememba* | N/A |
Dnevni razpon* | N/A |
Razpon 52 wk | 2.36-16.28 |
Povprečni obseg (10 dni) | 327.59K |
Povprečni obseg (3 meseci) | 4.90M |
Tržna kapitalizacija | 320.17M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 27.99M |
Prihodki | N/A |
EPS | -3.62 |
Dividenda (donosnost v %) | N/A |
Beta | 0.91 |
Datum naslednjega zaslužka | May 10, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|
Astria Therapeutics, Inc. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
No events scheduled |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Skupni prihodki | 0 | 0 | 0 | 0 | 0 |
Celotni odhodki iz poslovanja | 53.503 | 194.976 | 37.435 | 27.088 | 26.371 |
Celotna prodaja/splošni/upravni stroški Odhodki | 19.239 | 14.807 | 11.845 | 8.771 | 9.329 |
Raziskave in razvoj | 34.264 | 180.169 | 25.59 | 18.317 | 17.042 |
Prihodki iz poslovanja | -53.503 | -194.976 | -37.435 | -27.088 | -26.371 |
Prihodki (odhodki) od obresti, neto Neoperativni | 1.724 | 0.122 | 0.236 | 0.845 | 0.325 |
Drugo, neto | -0.055 | -0.058 | -0.101 | -0.05 | 0.176 |
Čisti dobiček pred obdavčitvijo | -51.834 | -194.912 | -37.3 | -26.293 | -25.87 |
Čisti dobiček po davkih | -51.834 | -194.912 | -37.3 | -26.293 | -25.87 |
Čisti dobiček pred dodatnimi postavkami | -51.834 | -194.912 | -37.3 | -26.293 | -25.87 |
Čisti dobiček | -51.834 | -194.912 | -37.3 | -26.293 | -25.87 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -51.834 | -219.349 | -37.3 | -26.293 | -25.87 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -51.834 | -219.349 | -37.3 | -26.293 | -25.87 |
Popravljen čisti dobiček | -51.834 | -219.349 | -37.3 | -26.293 | -25.87 |
Popravljene ponderirane povprečne delnice | 14.6206 | 8.92517 | 3.05864 | 1.86655 | 0.84249 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -3.54527 | -24.5764 | -12.195 | -14.0864 | -30.7067 |
Dividends per Share - Common Stock Primary Issue | |||||
Popravljen normalizirani dobiček na enoto čistega dobička | -3.54527 | -24.5764 | -12.195 | -14.0864 | -30.7067 |
Prihodki | 0 | ||||
Skupaj izredne postavke | |||||
Total Adjustments to Net Income | 0 | -24.437 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Skupni prihodki | 0 | 0 | 0 | 0 | 0 |
Celotni odhodki iz poslovanja | 14.29 | 12.386 | 11.449 | 15.378 | 9.508 |
Celotna prodaja/splošni/upravni stroški Odhodki | 4.699 | 4.688 | 4.832 | 5.02 | 3.815 |
Raziskave in razvoj | 9.591 | 7.698 | 6.617 | 10.358 | 5.693 |
Prihodki iz poslovanja | -14.29 | -12.386 | -11.449 | -15.378 | -9.508 |
Drugo, neto | 0.009 | -0.048 | -0.015 | -0.001 | -0.016 |
Čisti dobiček pred obdavčitvijo | -13.263 | -11.997 | -11.25 | -15.323 | -9.491 |
Čisti dobiček po davkih | -13.263 | -11.997 | -11.25 | -15.323 | -9.491 |
Čisti dobiček pred dodatnimi postavkami | -13.263 | -11.997 | -11.25 | -15.323 | -9.491 |
Čisti dobiček | -13.263 | -11.997 | -11.25 | -15.323 | -9.491 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -13.263 | -11.997 | -11.25 | -15.323 | -9.491 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -13.263 | -11.997 | -11.25 | -15.323 | -9.491 |
Popravljen čisti dobiček | -13.263 | -11.997 | -11.25 | -15.323 | -9.491 |
Popravljene ponderirane povprečne delnice | 18.6982 | 13.7424 | 13.017 | 13.017 | 13.0598 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.70932 | -0.87299 | -0.86426 | -1.17716 | -0.72673 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Popravljen normalizirani dobiček na enoto čistega dobička | -0.70932 | -0.87299 | -0.86426 | -1.17716 | -0.72673 |
Prihodki (odhodki) od obresti, neto Neoperativni | 1.018 | 0.437 | 0.214 | 0.056 | 0.033 |
Total Adjustments to Net Income | 0 | 0 | 0 | 0 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 127.075 | 46.325 | 38.958 | 38.915 | 17.463 |
Denarna sredstva in kratkoročne naložbe | 125.508 | 44.93 | 36.244 | 37.57 | 16.369 |
Denarna sredstva in ustrezniki | 1.853 | 22.999 | 5.432 | 5.956 | 16.369 |
Kratkoročne naložbe | 39 | 20 | 26.345 | 22.276 | 0 |
Prepaid Expenses | 1.446 | 1.274 | 2.237 | 1.345 | 1.094 |
Total Assets | 127.514 | 47.456 | 41.78 | 39.169 | 17.897 |
Property/Plant/Equipment, Total - Net | 0.394 | 0.966 | 2.349 | 0.056 | 0.321 |
Property/Plant/Equipment, Total - Gross | 0.377 | ||||
Accumulated Depreciation, Total | -0.321 | ||||
Other Long Term Assets, Total | 0.045 | 0.165 | 0.473 | 0.198 | 0.113 |
Total Current Liabilities | 5.203 | 6.39 | 5.032 | 4.171 | 6.016 |
Accounts Payable | 1.557 | 1.544 | 1.197 | 1.408 | 0.773 |
Accrued Expenses | 3.646 | 4.846 | 3.835 | 2.763 | 2.432 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 2.479 | |||
Total Liabilities | 5.203 | 6.787 | 6.06 | 4.227 | 6.105 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Long Term Debt | 0 | ||||
Other Liabilities, Total | 0 | 0.397 | 1.028 | 0.056 | 0.089 |
Total Equity | 122.311 | 40.669 | 35.72 | 34.942 | 11.792 |
Common Stock | 0.013 | 0.02 | 0.012 | 0.007 | 0.024 |
Additional Paid-In Capital | 481.709 | 301.546 | 259.305 | 232.243 | 183.202 |
Retained Earnings (Accumulated Deficit) | -455.809 | -260.897 | -223.597 | -197.304 | -171.434 |
Other Equity, Total | 0 | 0 | -0.004 | 0 | |
Total Liabilities & Shareholders’ Equity | 127.514 | 47.456 | 41.78 | 39.169 | 17.897 |
Total Common Shares Outstanding | 13.017 | 3.34746 | 2.07227 | 0.11903 | 0.3941 |
Other Current Liabilities, Total | 0 | 0.332 | |||
Preferred Stock - Non Redeemable, Net | 96.398 | 0 | 0 | 0 | |
Cash | 84.655 | 1.931 | 4.467 | 9.338 | |
Other Current Assets, Total | 0.121 | 0.121 | 0.477 | ||
Total Preferred Shares Outstanding | 0.03146 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 114.221 | 127.075 | 134.522 | 140.052 | 147.684 |
Denarna sredstva in kratkoročne naložbe | 112.816 | 125.508 | 131.777 | 139.52 | 146.92 |
Denarna sredstva in ustrezniki | 46.687 | 86.508 | 131.777 | 139.52 | 146.92 |
Kratkoročne naložbe | 66.129 | 39 | 0 | 0 | 0 |
Prepaid Expenses | 1.121 | 1.446 | 2.624 | 0.411 | 0.643 |
Other Current Assets, Total | 0.284 | 0.121 | 0.121 | 0.121 | 0.121 |
Total Assets | 114.653 | 127.514 | 135.129 | 140.945 | 148.74 |
Property/Plant/Equipment, Total - Net | 0.228 | 0.394 | 0.557 | 0.717 | 0.874 |
Other Long Term Assets, Total | 0.204 | 0.045 | 0.05 | 0.176 | 0.182 |
Total Current Liabilities | 4.967 | 5.203 | 4.7 | 3.988 | 4.406 |
Accounts Payable | 0.931 | 1.557 | 0.574 | 0.619 | 1.809 |
Accrued Expenses | 4.036 | 3.646 | 4.126 | 3.369 | 2.597 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 4.967 | 5.203 | 4.7 | 4.046 | 9.004 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 0 | 0 | 0.058 | 4.598 | |
Total Equity | 109.686 | 122.311 | 130.429 | 136.899 | 139.736 |
Preferred Stock - Non Redeemable, Net | 96.398 | 96.398 | 96.398 | 99.77 | 240.881 |
Common Stock | 0.013 | 0.013 | 0.013 | 0.077 | 0.023 |
Additional Paid-In Capital | 484.46 | 481.709 | 480.336 | 475.499 | 329.813 |
Retained Earnings (Accumulated Deficit) | -471.132 | -455.809 | -446.318 | -438.447 | -430.981 |
Total Liabilities & Shareholders’ Equity | 114.653 | 127.514 | 135.129 | 140.945 | 148.74 |
Total Common Shares Outstanding | 13.017 | 13.017 | 13.0095 | 12.8248 | 3.90283 |
Total Preferred Shares Outstanding | 0.03146 | 0.03146 | 0.03146 | 0.03255 | |
Other Equity, Total | -0.053 | 0 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -194.912 | -37.3 | -26.293 | -25.87 | -27.364 |
Denarna sredstva iz poslovanja | -30.151 | -32.485 | -26.569 | -23.465 | -26.836 |
Denarna sredstva iz poslovanja | 0.026 | 0.119 | 0.304 | ||
Nedenarne postavke | 168.066 | 1.448 | 1.568 | 1.524 | 2.158 |
Denarna sredstva Plačane obresti | 0 | 0.079 | 0.327 | ||
Spremembe v obratnem kapitalu | -3.305 | 3.367 | -1.87 | 0.762 | -1.934 |
Denarna sredstva pri naložbenju | -12.555 | 6.3 | -4.082 | -21.905 | 14.883 |
Kapitalski izdatki | -0.021 | -0.033 | -0.012 | 0 | -0.057 |
Celotne druge postavke denarnih tokov pri naložbenju | -12.534 | 6.333 | -4.07 | -21.905 | 14.94 |
Denarna sredstva pri financiranju | 104.284 | 40.86 | 25.62 | 44.295 | 4.726 |
Izdaja (odplačilo) delnic, neto | 104.284 | 40.86 | 25.62 | 47.143 | 8.059 |
Izdaja (odplačilo) dolga, neto | 0 | -2.848 | -3.333 | ||
Neto sprememba denarnih sredstev | 61.578 | 14.675 | -5.031 | -1.075 | -7.227 |
Postavke denarnega toka pri financiranju | 0 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -15.323 | -194.912 | -185.421 | -177.55 | -170.084 |
Cash From Operating Activities | -12.559 | -30.151 | -23.865 | -16.116 | -8.716 |
Non-Cash Items | 2.672 | 168.066 | 166.702 | 165.302 | 165.037 |
Changes in Working Capital | 0.092 | -3.305 | -5.146 | -3.868 | -3.669 |
Cash From Investing Activities | -27.099 | -12.555 | 26.445 | 26.445 | 26.445 |
Capital Expenditures | 0 | -0.021 | -0.021 | -0.021 | -0.021 |
Other Investing Cash Flow Items, Total | -27.099 | -12.534 | 26.466 | 26.466 | 26.466 |
Cash From Financing Activities | 0 | 104.284 | 104.267 | 104.261 | 104.261 |
Issuance (Retirement) of Stock, Net | 0 | 104.284 | 104.267 | 104.261 | 104.261 |
Net Change in Cash | -39.658 | 61.578 | 106.847 | 114.59 | 121.99 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
Fidelity Management & Research Company LLC | Investment Advisor | 11.9754 | 3351514 | 2974069 | 2022-12-31 | LOW |
Perceptive Advisors LLC | Private Equity | 7.8232 | 2189462 | 908265 | 2022-12-31 | MED |
Fairmount Funds Management LLC | Hedge Fund | 6.7939 | 1901397 | 989661 | 2022-12-31 | HIGH |
Deep Track Capital LP | Hedge Fund | 6.4907 | 1816531 | 1816531 | 2022-12-31 | MED |
Vivo Capital, LLC | Venture Capital | 6.0071 | 1681199 | 681199 | 2022-12-31 | MED |
Cormorant Asset Management, LP | Hedge Fund | 5.8957 | 1650000 | 450000 | 2022-12-31 | MED |
Altium Capital Management LP | Investment Advisor/Hedge Fund | 4.8429 | 1355372 | 910372 | 2022-12-31 | HIGH |
Driehaus Capital Management, LLC | Investment Advisor/Hedge Fund | 4.7784 | 1337315 | 680954 | 2022-12-31 | MED |
Logos Global Management LLC | Investment Advisor | 3.0906 | 864960 | 864960 | 2022-12-31 | HIGH |
Ikarian Capital LLC | Hedge Fund | 2.4125 | 675176 | -24264 | 2022-12-31 | HIGH |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.338 | 654326 | 123173 | 2022-12-31 | LOW |
Rosalind Advisors, Inc. | Hedge Fund | 2.3348 | 653438 | 653438 | 2021-12-31 | LOW |
Tri Locum Partners LP | Hedge Fund | 2.3273 | 651330 | 19751 | 2022-12-31 | HIGH |
Affinity Asset Advisors LLC | Hedge Fund | 1.6882 | 472482 | 72439 | 2022-12-31 | HIGH |
Sphera Funds Management Ltd. | Hedge Fund | 1.677 | 469340 | 469340 | 2022-12-31 | MED |
Ghost Tree Capital, LLC | Hedge Fund | 1.6079 | 450000 | -50000 | 2022-12-31 | HIGH |
Violin (Jonathan) | Individual Investor | 0.9409 | 263321 | 0 | 2022-04-13 | LOW |
Opaleye Management Inc. | Hedge Fund | 0.9351 | 261703 | 128203 | 2022-12-31 | MED |
Medical Strategy GmbH | Investment Advisor | 0.9026 | 252605 | -18814 | 2022-09-30 | LOW |
Point72 Asset Management, L.P. | Hedge Fund | 0.804 | 225000 | 225000 | 2022-12-31 | HIGH |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group500K+
Borzni posredniki
92K+
Aktivne stranke mesečno
$53M+
Mesečni obseg naložb
$30M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Astria Therapeutics, Inc. Company profile
O družbi Astria Therapeutics, Inc.
Astria Therapeutics, Inc., prej Catabasis Pharmaceuticals, Inc., je biofarmacevtsko podjetje. Podjetje se osredotoča na razvoj terapij za bolnike in družine z redkimi in nišnimi alergijskimi in imunološkimi boleznimi. Njen vodilni program, STAR-0215, je v predkliničnem razvoju za zdravljenje dednega angioedema (HAE). HAE je redka genetska bolezen, za katero so značilne hude, ponavljajoče se, nepredvidljive, boleče in včasih življenjsko nevarne otekline obraza, okončin, trebuha in dihalnih poti. STAR-0215 je monoklonsko protitelo, zaviralec plazemskega kalikreina, ki je zasnovan tako, da zagotavlja dolgotrajno preprečevanje napadov pri HAE.
Industry: | Bio Therapeutic Drugs |
75 State Street
Suite 1400
BOSTON
MASSACHUSETTS 02109
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com